News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Ivoclar Vivadent Withdraws Patent Suits Against 3M Company
July 19, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ST. PAUL, Minn. & SCHAAN, Liechtenstein--(BUSINESS WIRE)--3M and Ivoclar Vivadent announced today that they have settled their respective lawsuits in Germany and the U.S.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Manufacturing
FDA’s first AI-focused cGMP warning letter signals new scrutiny for manufacturers
July 16, 2026
·
3 min read
·
John Potter
Psychedelics
Final psychedelics guidance suggests FDA is ‘receptive’ to helping companies succeed
July 14, 2026
·
3 min read
·
Michael Gibney
Manufacturing
FDA proposes streamlined requirements for ‘hub-and-spoke’ manufacturing models
July 14, 2026
·
2 min read
·
Nick Paul Taylor
Editorial
Biotech’s China problem: An issue of national security or economic value for the US?
July 2, 2026
·
6 min read
·
Jef Akst
